JAPAN ANIMAL REFERRAL MEDICAL CENTER CO., LTD. Financials Japan Animal Referral Medical Center Co., Ltd.
Equities
6039
JP3740000009
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,002 JPY | +0.10% |
|
-0.15% | +15.99% |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 7,385 | 6,775 | 3,743 | 4,935 | 4,188 | 4,977 |
| Enterprise Value (EV) 1 | 10,605 | 9,358 | 5,897 | 6,794 | 7,041 | 7,036 |
| P/E ratio | 36.8 x | 23.9 x | 12.4 x | 17.8 x | 15.3 x | 11.9 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 3.27 x | 2.64 x | 1.37 x | 1.73 x | 1.41 x | 1.29 x |
| EV / Revenue | 4.7 x | 3.65 x | 2.16 x | 2.39 x | 2.36 x | 1.82 x |
| EV / EBITDA | 23.3 x | 15.1 x | 9.1 x | 10.9 x | 10.3 x | 7.1 x |
| EV / FCF | -19.4 x | 15.9 x | 16.1 x | 16.6 x | -26.3 x | 25.1 x |
| FCF Yield | -5.15% | 6.28% | 6.21% | 6.03% | -3.81% | 3.99% |
| Price to Book | 4.84 x | 3.71 x | 1.75 x | 2.12 x | 1.68 x | 1.34 x |
| Nbr of stocks (in thousands) | 2,410 | 2,420 | 2,434 | 2,373 | 2,318 | 2,732 |
| Reference price 2 | 3,065 | 2,800 | 1,538 | 2,080 | 1,807 | 1,822 |
| Announcement Date | 28/06/18 | 27/06/19 | 25/06/20 | 24/06/21 | 24/06/22 | 23/06/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 2,258 | 2,563 | 2,734 | 2,847 | 2,979 | 3,872 |
| EBITDA 1 | 456 | 621 | 648 | 625 | 681 | 991 |
| EBIT 1 | 280 | 397 | 431 | 405 | 440 | 580 |
| Operating Margin | 12.4% | 15.49% | 15.76% | 14.23% | 14.77% | 14.98% |
| Earnings before Tax (EBT) 1 | 253 | 390 | 450 | 411 | 422 | 533 |
| Net income 1 | 208 | 294 | 312 | 285 | 286 | 380 |
| Net margin | 9.21% | 11.47% | 11.41% | 10.01% | 9.6% | 9.81% |
| EPS 2 | 83.34 | 117.0 | 124.2 | 117.0 | 118.0 | 153.2 |
| Free Cash Flow 1 | -545.8 | 587.5 | 366 | 410 | -268.1 | 280.9 |
| FCF margin | -24.17% | 22.92% | 13.39% | 14.4% | -9% | 7.25% |
| FCF Conversion (EBITDA) | - | 94.61% | 56.48% | 65.6% | - | 28.34% |
| FCF Conversion (Net income) | - | 199.83% | 117.31% | 143.86% | - | 73.91% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 28/06/18 | 27/06/19 | 25/06/20 | 24/06/21 | 24/06/22 | 23/06/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,358 | 1,410 | 1,437 | 793 | 934 | 1,915 | 1,000 | 951 | 1,982 | 1,133 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 218 | 196 | 182 | 148 | 137 | 293 | 163 | 37 | 159 | 186 |
| Operating Margin | 16.05% | 13.9% | 12.67% | 18.66% | 14.67% | 15.3% | 16.3% | 3.89% | 8.02% | 16.42% |
| Earnings before Tax (EBT) 1 | 223 | 196 | 185 | 139 | 135 | 295 | 126 | 34 | 153 | 183 |
| Net income 1 | 158 | 134 | 127 | 96 | 87 | 197 | 82 | 18 | 97 | 123 |
| Net margin | 11.63% | 9.5% | 8.84% | 12.11% | 9.31% | 10.29% | 8.2% | 1.89% | 4.89% | 10.86% |
| EPS 2 | 65.32 | 57.33 | 53.47 | 40.49 | 37.51 | 85.02 | 34.73 | 6.580 | 35.61 | 44.60 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 07/11/19 | 05/11/20 | 04/11/21 | 03/02/22 | 04/08/22 | 04/11/22 | 09/02/23 | 03/08/23 | 09/11/23 | 08/02/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 3,220 | 2,583 | 2,154 | 1,859 | 2,853 | 2,059 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 7.061 x | 4.159 x | 3.324 x | 2.974 x | 4.189 x | 2.078 x |
| Free Cash Flow 1 | -546 | 588 | 366 | 410 | -268 | 281 |
| ROE (net income / shareholders' equity) | 15.1% | 17.5% | 15.8% | 12.8% | 11.8% | 12.2% |
| ROA (Net income/ Total Assets) | 3.17% | 4.13% | 4.48% | 4.3% | 4.29% | 4.66% |
| Assets 1 | 6,571 | 7,121 | 6,959 | 6,627 | 6,661 | 8,147 |
| Book Value Per Share 2 | 634.0 | 755.0 | 880.0 | 981.0 | 1,078 | 1,355 |
| Cash Flow per Share 2 | 369.0 | 516.0 | 515.0 | 510.0 | 459.0 | 701.0 |
| Capex 1 | 787 | 98 | 69 | 64 | 601 | 728 |
| Capex / Sales | 34.85% | 3.82% | 2.52% | 2.25% | 20.17% | 18.8% |
| Announcement Date | 28/06/18 | 27/06/19 | 25/06/20 | 24/06/21 | 24/06/22 | 23/06/23 |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +15.99% | 3.41Cr | |
| -39.04% | 89Cr |
- Stock Market
- Equities
- 6039 Stock
- Financials Japan Animal Referral Medical Center Co., Ltd.
